Repeated administration of Δ9-tetrahydrocannabinol produces a differential time related responsiveness on proenkephalin, proopiomelanocortin and corticotropin releasing factor gene expression in the hypothalamus and pituitary gland of the rat

Neuropharmacology

Volumn 38, Issue 3, 1999, Pages 433-439

  Corchero, Javier ^a   Manzanares, Jorge ^a   Fuentes, José A ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

9 tetrahydrocannabinol; Corticotropin releasing factor; Hypothalamus; mRNA; Pituitary; Proenkephalin; Proopiomelanocortin

Indexed keywords

CANNABINOID; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DELTA9(11) TETRAHYDROCANNABINOL; MESSENGER RNA; PROENKEPHALIN; PROOPIOMELANOCORTIN; ENKEPHALIN; PROTEIN PRECURSOR; TETRAHYDROCANNABINOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; GENE EXPRESSION REGULATION; HYPOPHYSIS; HYPOTHALAMUS; IN SITU HYBRIDIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; ANTERIOR HYPOTHALAMUS; DRUG ADMINISTRATION; DRUG EFFECT; GENETICS; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; METABOLISM; NEUROHYPOPHYSIS; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; CORTICOTROPIN-RELEASING HORMONE; DRUG ADMINISTRATION SCHEDULE; ENKEPHALINS; GENE EXPRESSION REGULATION; HYPOTHALAMUS; INJECTIONS, INTRAPERITONEAL; MALE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PITUITARY GLAND; PITUITARY GLAND, POSTERIOR; PRO-OPIOMELANOCORTIN; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY; TETRAHYDROCANNABINOL; TIME FACTORS; VENTROMEDIAL HYPOTHALAMIC NUCLEUS;

EID: 0032586759     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(98)00195-6     Document Type: Article

References (33)

1. Borsook, D., Falkowski, O., Burstein, R., Strassman, A., Konradi, C., Dauber, A., Comb, M., Hyman, S.E., 1994. Stress-induced regulation of a human proenkephalin-β-galactosidase fusion gene in the hypothalamus of transgenic mice. Mol. Endocrinol. 8, 116-125.
2. 9-tetrahydrocannabinol increases proopiomelanocortin gene expression in the arcuate nucleus of the rat hypothalamus. Eur. J. Pharmacol. 323, 193-195.
3. 9-tetrahydrocannabinol increases prodynorphin and preproenkephalin gene expression in the spinal cord of the rat. Life Sci. 61, PL39-PL43.
4. Devane, W.A., Hanus, L., Breuer, A., Pertwee, R.G., et al., 1992. Isolation and structure of a brain constituent that binds to the cannabinod receptor. Science 258, 1946-1949.
5. Dewey, W.L., 1986. Cannabinoid Pharmacology. Pharmacol. Rev. 38, 151-178.
6. Eipper, B.A., Mains, R.E., 1980. Structure and biosynthesis of proadrenocorticotropin/endorphin and related peptides. Endocr. Rev. 1, 1-27.
7. Emerson, R.B., Eipper, B.A., 1986. Characterization of pro-ACTH/endorphin derived peptides in rat hypothalamus. J. Neurosci. 6, 837-849.
8. García-García, L., Harbuz, M., Manzanares, J., Lightman, S.L., Fuentes, J.A., 1998. RU-486 blocks stress-induced enhancement of proenkephalin gene expression in the paraventricular nucleus of rat hypothalamus. Brain Res. 786, 215-218.
9. García-García, L., Llevelyn-Jones, V., Fernandez Fernandez, I., Fuentes, J.A., Manzanares, J., 1998. Acute and repeated ECS treatment increases CRF, POMC and PENK gene expression in selected regions of the rat hypothalamus. Neuroreport 9, 73-77.
10. Gramsch, C., Kleber, G., Höllt, V., Pasi, A., Mehracin, P., Herz, A., 1980. Proopiocortin fragments in human and rat brain: β-endorphin and α-MSH are the predominant peptides. Brain Res. 192, 109-119.
11. Höllt, V., Haarman, I., 1984. Corticotropin-releasing factor differentially regulates proopiomelanocortin messenger ribonucleic acid levels in anterior as compared to intermediate pituitary lobes of rats. Biochem. Biophys. Res. Commun. 124, 407-415.
12. Lightman, S.L., 1988. The neuroendocrine paraventricular hypothalamus: receptor, signal transduction, mRNA and neurosecretion. J. Exp. Biol. 139, 31-49.
13. Lightman, S.L., Young, W.S. III, 1988. Corticotrophin-releasing factor, vasopressin and pro-opiomelanocortin mRNA responses to stress and opiates in the rat. J. Physiol. 403, 511-523.
14. Manzanares, J., Corchero, J., Romero, J., Fernandez-Ruiz, J.J., Ramos, J.A., Fuentes, J.A., 1998. Chronic administration of cannabinoids regulates proenkephalin mRNA levels in selected regions of the rat brain. Mol. Brain Res. 55, 126-132.
15. Matsuda, L.A., Lolait, S.J., Browstein, M.J., Young, A.C., Bonner, T.I., 1990. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561-564.
16. Nikolarakis, K.E., Almeida, O.F.X., Herz, A., 1986. Stimulation of hypothalamic β-endorphin and dynorphin release by corticotropin-releasing factor (in vitro). Brain Res. 399, 152-155.
17. Priest, C.A., Eckersell, C.B., Micevych, P.E., 1995. Estrogen regulates preproenkephalin-A mRNA levels in the rat ventromedial nucleus: temporal and cellular aspects. J. Neuroendocrinology 2, 251-262.
18. Priest, C.A., Borsook, D., Pfaff, D.W., 1997. Estrogen and stress interact to regulate the hypothalamic expression of a human proenkephalin promoter-beta-galactosidase fusion gene in a site-specific and sex specific manner. J. Neuroendocrinology 9, 317-326.
19. Pugh G. Jr., Mason, D.J. Jr., Combs V., Welch, S.P., 1997. Involvement of dynorphin B in the antinociceptive effects of the cannabinoid CP 55,940 in the spinal cord. J. Pharmacol. Exp. Ther. 281: 730-737.
20. Rang H.P., Dale M.M., 1991 Drugs Affecting Major Organs Systems: The Gastrointestinal Tract. In: Pharmacology, 2nd ed. Churchill Livingstone, Edinburgh, pp. 458-459.
21. 9-tetrahydrocannabinol-induced analgesia in mice. Eur. J. Pharmacol. 301, 75-81.
22. 9-tetrahydrocannabinol-induced analgesia by morphine in mice: Involvement of μ- and κ-opioid receptors. Eur. J. Pharmacol. 318, 11-16.
23. Reche I., Ruiz-Gayo, M., Fuentes, J.A., 1998. Inhibition of opioid-degrading enzymes potentiates Δ-9 tetrahydrocannabinol-induced antinociception in mice, Neuropharmacology 37, 215-222.
24. Rivier, C., Imaki, T., Vale, W., 1990. Prolonged exposure to alcohol: effects on CRF mRNA levels, and CRF- and stress-induced ACTH secretion in the rat. Brain Res. 520, 1-5.
25. Rivier, C., Lee, S., 1994. Stimulatory effect of cocaine on ACTH secretion: role of the hypothalamus. Mol. Cell Neurosci. 5, 189-195.
26. 37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats. J. Pharmacol. Exp. Ther. 276, 56-64.
27. Rodriguez de Fonseca, F., Carrera, M.R.A., Navarro, M., Koob, G.F., Weiss, F., 1997. Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science 276, 2050-2054.
28. Romano, G.J., Mobbs, C.V., Howells, R.D., Pfaff, D.W., 1989. Estrogen regulation of proenkephalin gene expression in the ventromedial hypothalamus of the rat: temporal qualities and synergism with progesterone. Mol. Brain Res. 5, 51-58.
29. 9-tetrahydrocannabinol in rats: possible role of pituitary adrenal axis. Life Sci. 56, 2169-2176.
30. Stella, N., Schweitzer, P., Piomelli, D., 1997. A second endogenous cannabinoid that modulates long-trem potentiation. Nature 388, 773-778.
31. Vela, G., Ruiz-Gayo, M., Fuentes, J.A., 1995. Anandamide decreases naloxone precipitated withdrawal signs in mice chronically treated with morphine. Neuropharmacology 34, 665-668.
32. Weidenfeld, J., Feldman, S., Mechoulam, R., 1994. Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamus-pituitary-adrenal axis in the rat. Neuroendocrinology 59, 110-112.
33. Young, W.S. III, Bonner, T.I., Barnn, M.R., 1986. Mesencephalic dopaminergic neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. Proc. Natl. Acad. Sci. USA 83, 9827-9831.